186 related articles for article (PubMed ID: 37388539)
1. PKM2 dictates the poised chromatin state of
Pandkar MR; Raveendran A; Biswas K; Mutnuru SA; Mishra J; Samaiya A; Malys T; Mitrophanov AY; Sharan SK; Shukla S
NAR Cancer; 2023 Sep; 5(3):zcad032. PubMed ID: 37388539
[TBL] [Abstract][Full Text] [Related]
2. [Shikonin induces hepatocellular carcinoma cell apoptosis by suppressing PKM2/PHD3/HIF-1
Zhang H; Chen Z; Zhao X; Huo Q; Cheng X
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jan; 43(1):92-98. PubMed ID: 36856215
[TBL] [Abstract][Full Text] [Related]
3. 6-Phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia.
Obach M; Navarro-Sabaté A; Caro J; Kong X; Duran J; Gómez M; Perales JC; Ventura F; Rosa JL; Bartrons R
J Biol Chem; 2004 Dec; 279(51):53562-70. PubMed ID: 15466858
[TBL] [Abstract][Full Text] [Related]
4. Cynaroside prevents macrophage polarization into pro-inflammatory phenotype and alleviates cecal ligation and puncture-induced liver injury by targeting PKM2/HIF-1α axis.
Pei L; Le Y; Chen H; Feng J; Liu Z; Zhu J; Wang C; Chen L; Dou X; Lu D
Fitoterapia; 2021 Jul; 152():104922. PubMed ID: 33984439
[TBL] [Abstract][Full Text] [Related]
5. Pyruvate Kinase M2 Is Required for the Expression of the Immune Checkpoint PD-L1 in Immune Cells and Tumors.
Palsson-McDermott EM; Dyck L; Zasłona Z; Menon D; McGettrick AF; Mills KHG; O'Neill LA
Front Immunol; 2017; 8():1300. PubMed ID: 29081778
[TBL] [Abstract][Full Text] [Related]
6. PKM2 and HIF-1α regulation in prostate cancer cell lines.
Hasan D; Gamen E; Abu Tarboush N; Ismail Y; Pak O; Azab B
PLoS One; 2018; 13(9):e0203745. PubMed ID: 30216369
[TBL] [Abstract][Full Text] [Related]
7. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth.
Sun Q; Chen X; Ma J; Peng H; Wang F; Zha X; Wang Y; Jing Y; Yang H; Chen R; Chang L; Zhang Y; Goto J; Onda H; Chen T; Wang MR; Lu Y; You H; Kwiatkowski D; Zhang H
Proc Natl Acad Sci U S A; 2011 Mar; 108(10):4129-34. PubMed ID: 21325052
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
[No Abstract] [Full Text] [Related]
9. JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1α-mediated glucose metabolism.
Wang HJ; Hsieh YJ; Cheng WC; Lin CP; Lin YS; Yang SF; Chen CC; Izumiya Y; Yu JS; Kung HJ; Wang WC
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):279-84. PubMed ID: 24344305
[TBL] [Abstract][Full Text] [Related]
10. Combination Treatment Using Pyruvate Kinase M2 Inhibitors for the Sensitization of High Density Triple-negative Breast Cancer Cells.
Lee JS; Oh Y; Lee JS; Park JH; Shin JK; Han JH; Kim HS; Yoon S
In Vivo; 2022; 36(5):2105-2115. PubMed ID: 36099094
[TBL] [Abstract][Full Text] [Related]
11. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C
J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057
[TBL] [Abstract][Full Text] [Related]
12. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Pyruvate kinase M2 (PKM2) by shikonin attenuates isoproterenol-induced acute myocardial infarction via reduction in inflammation, hypoxia, apoptosis, and fibrosis.
Rihan M; Sharma SS
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):145-159. PubMed ID: 37382601
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression.
Zhao H; Jiang R; Feng Z; Wang X; Zhang C
J Transl Med; 2023 Nov; 21(1):833. PubMed ID: 37980488
[TBL] [Abstract][Full Text] [Related]
15. Melittin ameliorates inflammation in mouse acute liver failure via inhibition of PKM2-mediated Warburg effect.
Fan XG; Pei SY; Zhou D; Zhou PC; Huang Y; Hu XW; Li T; Wang Y; Huang ZB; Li N
Acta Pharmacol Sin; 2021 Aug; 42(8):1256-1266. PubMed ID: 32939034
[TBL] [Abstract][Full Text] [Related]
16. Suppression of myeloid PFKFB3-driven glycolysis protects mice from choroidal neovascularization.
Liu Z; Mao X; Yang Q; Zhang X; Xu J; Ma Q; Zhou Y; Da Q; Cai Y; Sopeyin A; Dong Z; Hong M; Caldwell RB; Sodhi A; Huo Y
Br J Pharmacol; 2022 Nov; 179(22):5109-5131. PubMed ID: 35830274
[TBL] [Abstract][Full Text] [Related]
17. Shikonin ameliorated mice colitis by inhibiting dimerization and tetramerization of PKM2 in macrophages.
Huang B; Wang Q; Jiang L; Lu S; Li C; Xu C; Wang C; Zhang E; Zhang X
Front Pharmacol; 2022; 13():926945. PubMed ID: 36059938
[TBL] [Abstract][Full Text] [Related]
18. The transcription factor TEAD4 enhances lung adenocarcinoma progression through enhancing PKM2 mediated glycolysis.
Hu Y; Mu H; Deng Z
Cell Biol Int; 2021 Oct; 45(10):2063-2073. PubMed ID: 34196069
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
[TBL] [Abstract][Full Text] [Related]
20. Shikonin Inhibits Tumor Growth of ESCC by suppressing PKM2 mediated Aerobic Glycolysis and STAT3 Phosphorylation.
Zhang Q; Liu Q; Zheng S; Liu T; Yang L; Han X; Lu X
J Cancer; 2021; 12(16):4830-4840. PubMed ID: 34234853
[No Abstract] [Full Text] [Related]
[Next] [New Search]
